XML 29 R20.htm IDEA: XBRL DOCUMENT v3.22.1
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS
9 Months Ended
Sep. 30, 2021
Accounting Changes and Error Corrections [Abstract]  
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

 

14.RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

 

As previously reported, on June 4, 2021, the Audit and Finance Committee determined, based on the recommendation of management and in consultation with CohnReznick that the Company’s financial statements which were included in its Annual Report on Form 10-K for the year ended December 31, 2020 and Quarterly Reports on Form 10-Q for the quarters ended March 31, 2020, June 30, 2020, and September 30, 2020 as filed with the SEC should no longer be relied upon due to the Inventory Costing Errors and that management’s reports on the effectiveness of internal control over financial reporting, press releases, and investor communications describing the Company’s financial statements for such periods should no longer be relied upon. The Company’s management identified the Inventory Costing Errors during its inventory testing procedures for the preparation of the Company’s financial statements for the quarterly period ended March 31, 2021. At the time of the June 2021 disclosure, the Company estimated and disclosed that the Inventory Costing Errors were expected to increase 2020 net loss reported on the Annual Report on Form 10-K for the year ended December 31, 2020 by $1.9 million to $2.3 million. The Company has determined that the Inventory Costing Errors increased 2020 net loss by $2,010,084.

 

The correction of the Inventory Costing Errors resulted in the determination that certain contracts were in a loss position and certain inventory items required additional reserves. The Company re-evaluated the sufficiency of its provisions for loss contracts and inventory reserves that it had previously recorded and concluded that increases to these reserves were required. It was further determined by management that the appropriate starting point for increasing the Insufficient Reserves was during the fourth quarter of 2019.

 

On November 16, 2021, the Audit and Finance Committee determined, based on the analysis and recommendation of management and in consultation with CohnReznick, that the Company’s financial statements as of and for the period ended December 31, 2019 which were included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 should no longer be relied upon due to errors in such financial statements relating to the recording and reporting of the Insufficient Reserves, that, similarly, management’s reports on the effectiveness of internal control over financial reporting, press releases, and investor communications describing the Company’s financial statements for such period should no longer be relied upon, and stated that the Company expected to restate its Annual Report on Form 10-K for the years ended December 31, 2020 and December 31, 2019, and its Original Forms 10-Q by filing a Comprehensive Form 10-K/A.

 

The Company, upon conducting an analysis of the impact of the Insufficient Reserves on previously reported financial results, determined that net loss for the years ended December 31, 2020 and 2019 was $324,231 and $2,189,728, respectively, greater than the net loss reported in the Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019.

 

Considering both the Inventory Costing Errors and the Insufficient Reserves, the Company determined that the net loss for the years ended December 31, 2020 and 2019 was $2,334,315 and $2,300,083, respectively, greater than the net loss reported in the Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and net loss for the quarters ended March 31, 2020 and June 30, 2020 is $544,836 and $763,730, respectively, greater than the net loss reported in the respective Quarterly Reports on Form 10-Q for such periods and the net income for the quarter ended September 30, 2020 was $24,556 more than the net income reported in the Quarterly Report for such period.

 

The Inventory Costing Errors resulted from software processing and coding errors, inconsistent units of measure being used for quantities ordered and quantities received of certain purchased parts, incorrect accruals to accounting periods of the cost of certain goods received and the Company not having a procedure to address over- or under-absorbed overhead costs at the end of accounting periods. The Inventory Costing Errors affected the income reported with respect to the Company’s Non-POC Contracts. The Inventory Costing Errors did not affect income reported with respect to the Company’s POC Contracts. The Loss Contract Reserve and the Additional Inventory Reserves also only affected the income reported with respect to the Company’s Non-POC Contracts, and did not affect the income reported with respect to the Company’s POC Contracts. The Inventory Costing Errors and the Insufficient Reserves did not affect either prior reported revenue or cash flow for fiscal 2020 and 2019.

 

Management has considered the effect of the Inventory Costing Errors and the Insufficient Reserves on the Company’s prior conclusions of the adequacy of its internal control over financial reporting and disclosure controls and procedures as of the end of each of the applicable periods. As a result of the Inventory Costing Errors and the Insufficient Reserves, management has determined that a material weakness existed in the Company’s internal control over financial reporting as of the end of the quarterly periods ended March 31, 2020, June 30, 2020, September 30, 2020 and for the years ended December 31, 2020 and 2019. See Part II Item 9A – Controls and Procedures within the Comprehensive Form 10-K/A for a description of these matters.

 

As a result of the restatement included caused by the Inventory Costing Errors and Insufficient Reserves, the Company reported net loss for the years ended December 31, 2020 and December 31, 2019 which was $2,334,315 and $2,300,083, respectively, greater than the net loss reported in the Original Form 10-K and the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019, net loss for the quarters ended March 31, 2020 and June 30, 2020 which was $544,836 and $763,730, respectively, greater than the net loss reported in the respective Original Forms 10-Q, and net income for the quarter ended September 30, 2020 which is $24,556 greater than the net income reported in the Original Form 10-Q. The Inventory Costing Errors and the Insufficient Reserves did not affect reported revenue or cash flows for the years ended December 31, 2020 or December 31, 2019, or for the quarters ended March 31, June 30 and September 30, 2020.

 

2020 and 2019 Restatement

 

The following is a discussion of the restatement adjustments that were made to the Company’s previously issued December 31, 2020 and December 31, 2019 consolidated financial statements due to the Inventory Costing Errors, Loss Contract Reserve and Additional Inventory Reserves.

 

(a) Inventory Costing Errors

 

The Company determined that the Inventory Costing Errors resulted in incorrectly reported inventory values and reported income for the annual periods ended December 31, 2020 and December 31, 2019, and the quarterly periods ended March 31, 2020, June 30, 2020 and September 30, 2020. The Inventory Costing Errors were comprised of the following:

 

1)   Labor costs for work in process were overstated in the detailed inventory records due to an automated reversing entry not processing correctly;

 

2)   A customized IT program to calculate weighted average cost was not tested thoroughly enough, which allowed errors in average cost calculations to occur in certain situations;

 

3)   Units of measure were not consistent between quantities ordered and quantities received for certain classes of purchased parts, which resulted in overstatements of inventory values due to units of measure not being consistent with unit prices on purchase orders to suppliers;

 

4)   The cost of goods received which had not yet processed through the Company’s quality inspection process at the time of the period-end accounting closes were not properly accrued to the period financial statements;

 

5)   The Company did not have a process to address over-absorbed or under-absorbed overhead costs at the end of each accounting period.

 

(b) Loss Contract Reserve

 

After correcting its financial statements for the Inventory Costing Errors, the Company determined that is was a party to some contracts to deliver product upon which the Company would lose money, and thus the Company’s Loss Contract Reserve was increased accordingly for the year ended December 31, 2020 and December 31, 2019, and for the quarterly periods ended March 31, 2020, June 30, 2020 and September 30, 2020.

 

(c) Additional Inventory Reserves

 

After correcting its financial statements for the Inventory Costing Errors, the Company determined that its inventory required additional reserves to reflect current market value and demand, and thus the Company’s Inventory Reserves were increased accordingly for the year ended December 31, 2020 and December 31, 2019, and for the quarterly periods ended March 31, 2020, June 30, 2020 and September 30, 2020.

 

(d) Income taxes

 

There were no material tax adjustments to the Company’s provision for/(benefit from) income taxes or net deferred tax assets (liabilities) related to the impact of the 2020 and 2019 restatement.

 

 

The following tables present the impact of the restatement on the Company’s previously reported financial statements as of December 31, 2020 and September 30, 2020:

 

Impact on Consolidated Balance Sheets

The effect of the Restatement described above on the accompanying consolidated balance sheet as of December 31, 2020 is as follows:

 

                                       
   Consolidated Balance Sheet as at December 31, 2020 
   As Previously
Reported
   Inventory Costing
Errors
   Loss Contract
Reserve
   Additional
Inventory Reserve
   As Restated 
ASSETS                    
Current Assets:                         
Cash  $6,033,537   $   $   $   $6,033,537 
Accounts receivable, net   4,962,906                   4,962,906 
Contract assets   19,729,638                   19,729,638 
Inventory   9,567,921    (1,875,950)        (1,305,683)   6,386,288 
Refundable income taxes   40,000                   40,000 
Prepaid expenses and other current assets   534,857                   534,857 
                          
Total Current Assets   40,868,859    (1,875,950)       (1,305,683)   37,687,226 
                          
Operating lease right-of-use assets   4,075,048                   4,075,048 
Property and equipment, net   2,521,742                   2,521,742 
Intangibles, net   250,000                   250,000 
Goodwill   1,784,254                   1,784,254 
Other assets   191,179                   191,179 
                          
Total Assets  $49,691,082   $(1,875,950)  $   $(1,305,683)  $46,509,449 
                          
Liabilities and Shareholders’ Deficit                         
Current Liabilities:                         
Accounts payable  $12,092,684   $   $   $   $12,092,684 
Accrued expenses   5,693,518    244,403              5,937,921 
Contract liabilities   1,650,549                   1,650,549 
Loss reserve   800,971         1,208,276         2,009,247 
Current portion of long-term debt   6,501,666                   6,501,666 
Operating lease liabilities   1,819,237                   1,819,237 
Income taxes payable   862    86              948 
                          
Total Current Liabilities   28,559,487    244,489    1,208,276        30,012,252 
                          
Line of credit   20,738,685                   20,738,685 
Long-term operating lease liabilities   2,537,149                   2,537,149 
Long-term debt, net of current portion   6,205,095                   6,205,095 
                          
Total Liabilities   58,040,416    244,489    1,208,276        59,493,181 
                          
Shareholders’ Deficit:                         
Common stock   11,951                   11,951 
Additional paid-in capital   72,005,841                   72,005,841 
Accumulated deficit   (80,367,126)   (2,120,439)   (1,208,276)   (1,305,683)   (85,001,524)
Total Shareholders Deficit   (8,349,334)   (2,120,439)   (1,208,276)   (1,305,683)   (12,983,732)
Total Liabilities and Shareholders Deficit  $49,691,082   $(1,875,950)  $   $(1,305,683)  $46,509,449 

 

 

The effect of the Restatement described above on the accompanying consolidated statement of operations for the three and nine months ended September 30, 2020 is as follows:

                     
   Consolidated Statement of Operation For the three months ended September 30, 2020 (Unaudited) 
     
   As Previously
Reported
   Inventory
Costing Errors
   Loss Contract
Reserve
   Inventory Reserve   As Restated 
Revenue   $25,576,718   $   $   $   $25,576,718 
Cost of sales    21,394,243    112,446    (206,159)   69,157    21,369,687 
Gross profit    4,182,475    (112,446)   206,159    (69,157)   4,207,031 
Selling, general and administrative expenses    3,050,644                   3,050,644 
Profit from operations    1,131,831    (112,446)   206,159    (69,157)   1,156,387 
                          
Other expense:                         
Interest expense    (309,008)                  (309,008)
Income before provision for income taxes    822,823    (112,446)   206,159    (69,157)   847,379 
                          
Provision for income taxes    7,614                7,614 
Net Income   $815,209   $(112,446)  $206,159   $(69,157)  $839,765 
Income per common share - basic   $0.07   $(0.01)  $0.02   $(0.01)  $0.07 
Income per common share - diluted   $0.07   $(0.01)  $0.02   $(0.01)  $0.07 
Basic    11,894,469                11,894,469 
Diluted    11,894,469                11,917,149 

                               
                                       
   Consolidated Statement of Operation For the nine months ended September 30, 2020 (Unaudited) 
     
   As Previously Reported   Inventory
Costing Errors
   Loss Contract
Reserve
   Inventory Reserve   As Restated 
Revenue   $62,175,872   $   $   $   $62,175,872 
Cost of sales    54,715,508    938,689    (6,753)   352,074    55,999,518 
Gross profit    7,460,364    (938,689)   6,753    (352,074)   6,176,354 
Selling, general and administrative expenses    8,958,986                   8,958,986 
Loss from operations    (1,498,622)   (938,689)   6,753    (352,074)   (2,782,632)
                          
Other expense:                         
Interest expense    (1,085,805)                  (1,085,805)
Loss before provision for income taxes    (2,584,427)   (938,689)   6,753    (352,074)   (3,868,437)
                          
Provision for income taxes    9,714                9,714 
Net loss   $(2,594,141)  $(938,689)  $6,753   $(352,074)  $(3,878,151)
Loss per common share - basic   $(0.22)  $(0.08)  $0.00   $(0.03)  $(0.33)
Loss per common share - diluted   $(0.22)  $(0.08)  $0.00   $(0.03)   (0.33)
Basic    11,862,506                11,862,506 
Diluted    11,862,506                11,862,506 

 

 

Cumulative Effect of Prior Period Adjustments

The following table presents the impact of the Restatement on the Company’s shareholders’ deficit as of December 31, 2019 (as restated), March 31, 2020 (as restated), June 30, 2020 (as restated), September 30, 2020 (as restated) and December 31, 2020 (as restated):

 

                     
   Common Stock Shares   Common Stock   Additional Paid-in Capital   Accumulated Deficit   Total Shareholders’ Deficit 
Balance, December 31, 2019
(As Restated)
   11,818,830   $11,819   $71,294,629   $(81,346,771)  $(10,040,323)
Net Loss (as previously reported)                 $(2,812,519)  $(2,812,519)
Inventory Costing Errors               (315,999)   (315,999)
Loss Contract Reserve               (9,371)   (9,371)
Inventory Reserve               (219,466)   (219,466)
Cumulative restatement adjustments               (544,836)   (544,836)
Net Loss (as restated)                  (3,357,355)   (3,357,355)
Stock-based compensation   18,388    18    347,167        347,185 
Balance, March 31, 2020
(As Restated)
   11,837,218   $11,837   $71,641,796   $(84,704,126)  $(13,050,493)
Net Loss (as previously reported)                 $(596,831)  $(596,831)
Inventory Costing Errors               (510,244)   (510,244)
Loss Contract Reserve               (190,035)   (190,035)
Inventory Reserve               (63,451)   (63,451)
Cumulative restatement adjustments               (763,730)   (763,730)
Net Loss (as restated)                  (1,360,561)   (1,360,561)
Stock-based compensation   18,388    19    189,184        189,203 
Balance, June 30, 2020
(As Restated)
   11,855,606   $11,856   $71,830,980   $(86,064,687)  $(14,221,851)
Net Income (as previously reported)                 $815,209   $815,209 
Inventory Costing Errors               (112,446)   (112,446)
Loss Contract Reserve               206,159    206,159 
Inventory Reserve               (69,157)   (69,157)
Cumulative restatement adjustments               24,556    24,556 
Net Income (as restated)                  839,765    839,765 
Stock-based compensation   70,571    70    141,031        141,101 
Balance, September 30, 2020
(As Restated)
   11,926,177   $11,926   $71,972,011   $(85,224,922)  $(13,240,985)
Net Income             $1,273,703   $1,273,703 
Inventory Costing Errors               (1,071,395)   (1,071,395)
Loss Contract Reserve               99,921    99,921 
Inventory Reserve               (78,831)   (78,831)
Cumulative restatement adjustments               (1,050,305)   (1,050,305)
Net Income (as restated)                  223,398    223,398 
Stock-based compensation   25,094    25    33,830        33,855 
Balance, December 31, 2020
(As Restated)
   11,951,271   $11,951   $72,005,841   $(85,001,524)  $(12,983,732)

 

 

 

Impact on Consolidated Statement of Cash Flows

The effect of the Restatement described above on the accompanying consolidated statement of cash flows for the nine months ended September 30, 2020 is as follows:

                       
   Consolidated Statements of Cash Flows for the nine months ended September 30, 2020 (Unaudited) 
   As Previously Reported   Inventory Costing Errors   Loss Contract Reserve   Inventory Reserve   As Restated 
Cash flows from operating activities:                         
Net Loss   $(2,594,141)  $(938,689)  $6,753   $(352,074)  $(3,878,151)
Adjustments to reconcile net loss to net cash used in operating activities:                         
Depreciation and amortization    769,690                   769,690 
Amortization of debt issuance cost    80,764                   80,764 
Cash expended in excess of rent expense    (115,932)                  (115,932)
Stock-based compensation expense    677,489                   677,489 
Bad debt expense    (47,410)               (47,410)
Changes in operating assets and liabilities:                         
Increase in accounts receivable    (232,310)                  (232,310)
Increase in contract assets    (3,128,460)                  (3,128,460)
Increase in inventory    (2,850,707)   852,222         352,074    (1,646,411)
Decrease in prepaid expenses and other current assets    121,075                   121,075 
Decrease in refundable income taxes    439,445                439,445 
Increase in accounts payable and accrued expenses    5,770,902    86,467              5,857,369 
Decrease in contract liabilities    (1,092,266)                  (1,092,266)
Decrease in loss reserve    (1,081,516)        (6,753)        (1,088,269)
Net cash used in operating activities    (3,283,377)               (3,283,377)
Cash flows from investing activities:                         
Purchase of property and equipment    (11,888)               (11,888)
Net cash used in investing activities    (11,888)               (11,888)
Cash flows from financing activities:                         
Proceeds from PPP loan    4,795,000                   4,795,000 
Payments on long-term debt    (1,855,209)                  (1,855,209)
Debt issuance costs    (107,540)               (107,540)
Net cash provided by financing activities    2,832,251                2,832,251 
Net decrease in cash and restricted cash    (463,014)                  (463,014)
Cash and restricted cash at beginning of year    5,432,793                5,432,793 
Cash and restricted cash at end of year   $4,969,779   $   $   $   $4,969,779 
Supplemental schedule of cash flow information:                         
Cash paid during the year for interest   $1,156,126   $   $   $   $1,156,126 
Cash (received) from income taxes   $(449,749)  $   $   $   $(449,749)